SG10201602846TA - 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents - Google Patents

4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents

Info

Publication number
SG10201602846TA
SG10201602846TA SG10201602846TA SG10201602846TA SG10201602846TA SG 10201602846T A SG10201602846T A SG 10201602846TA SG 10201602846T A SG10201602846T A SG 10201602846TA SG 10201602846T A SG10201602846T A SG 10201602846TA SG 10201602846T A SG10201602846T A SG 10201602846TA
Authority
SG
Singapore
Prior art keywords
phenylpyrazolo
phenylamino
amino
manufacture
antiviral agents
Prior art date
Application number
SG10201602846TA
Other languages
English (en)
Inventor
Peter Wutzler
Michaela Schmidtke
Vadim Makarov
Original Assignee
Dritte Patentportfolio Beteiligungs Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE201110116373 external-priority patent/DE102011116373A1/de
Application filed by Dritte Patentportfolio Beteiligungs Gmbh & Co Kg filed Critical Dritte Patentportfolio Beteiligungs Gmbh & Co Kg
Publication of SG10201602846TA publication Critical patent/SG10201602846TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
SG10201602846TA 2011-10-14 2012-10-15 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents SG10201602846TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE201110116373 DE102011116373A1 (de) 2011-10-14 2011-10-14 Methode zur Herstellung von 4-Amino-3-arylamino-6-arylpyrazolo[3, 4-d]pyrimidinen
DE102011116384 2011-10-20

Publications (1)

Publication Number Publication Date
SG10201602846TA true SG10201602846TA (en) 2016-05-30

Family

ID=47071252

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201401351PA SG11201401351PA (en) 2011-10-14 2012-10-15 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances
SG10201602846TA SG10201602846TA (en) 2011-10-14 2012-10-15 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201401351PA SG11201401351PA (en) 2011-10-14 2012-10-15 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances

Country Status (22)

Country Link
US (1) US9790225B2 (de)
EP (1) EP2766367B1 (de)
JP (1) JP6071012B2 (de)
KR (1) KR20140095467A (de)
CN (1) CN103946224A (de)
AU (1) AU2012322750B2 (de)
BR (1) BR112014008815B1 (de)
CA (1) CA2850439C (de)
DK (1) DK2766367T3 (de)
ES (1) ES2924828T3 (de)
HR (1) HRP20220928T1 (de)
HU (1) HUE059217T2 (de)
IL (1) IL231934A (de)
LT (1) LT2766367T (de)
MX (1) MX2014003987A (de)
PL (1) PL2766367T3 (de)
PT (1) PT2766367T (de)
RU (1) RU2014118953A (de)
SG (2) SG11201401351PA (de)
SI (1) SI2766367T1 (de)
WO (1) WO2013053942A1 (de)
ZA (1) ZA201402226B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2662822T3 (es) 2015-03-04 2018-04-09 Scandion Oncology A/S Derivados de 4-amino-3-fenilamino-6-fenilpirazol[3,4-d]pirimidina para uso como inhibidores de la BCRP en tratamientos terapéuticos
KR102205570B1 (ko) 2018-09-12 2021-01-20 김홍기 뿌리식물 수경재배용 시트

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965643A (en) 1960-12-20 Derivatives of pyrazolo
US3551428A (en) 1956-02-10 1970-12-29 Ciba Geigy Corp New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines
DE3712735A1 (de) 1987-04-15 1988-11-10 Boehringer Mannheim Gmbh Neue pyrazolo(3,4-d)pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel
CA2100863A1 (en) 1991-01-23 1992-07-24 David A. Bullough Adenosine kinase inhibitors
TW444018B (en) * 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
US5646152A (en) 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
CZ27399A3 (cs) 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
DE102006029074A1 (de) * 2006-06-22 2007-12-27 Friedrich-Schiller-Universität Jena 4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe

Also Published As

Publication number Publication date
AU2012322750A1 (en) 2014-04-24
PT2766367T (pt) 2022-08-12
CA2850439A1 (en) 2013-04-18
HUE059217T2 (hu) 2022-10-28
PL2766367T3 (pl) 2022-08-22
ZA201402226B (en) 2015-05-27
KR20140095467A (ko) 2014-08-01
BR112014008815A2 (pt) 2017-04-25
IL231934A (en) 2017-03-30
MX2014003987A (es) 2014-09-22
SG11201401351PA (en) 2014-08-28
BR112014008815B1 (pt) 2021-01-12
ES2924828T3 (es) 2022-10-11
LT2766367T (lt) 2022-08-25
US20140296259A1 (en) 2014-10-02
NZ623573A (en) 2016-08-26
RU2014118953A (ru) 2015-11-20
CN103946224A (zh) 2014-07-23
EP2766367B1 (de) 2022-05-18
US9790225B2 (en) 2017-10-17
EP2766367A1 (de) 2014-08-20
IL231934A0 (en) 2014-05-28
CA2850439C (en) 2020-04-07
DK2766367T3 (da) 2022-08-01
JP2014528468A (ja) 2014-10-27
AU2012322750B2 (en) 2016-11-10
WO2013053942A1 (de) 2013-04-18
JP6071012B2 (ja) 2017-02-01
SI2766367T1 (sl) 2022-10-28
HRP20220928T1 (hr) 2022-10-28

Similar Documents

Publication Publication Date Title
IL257410A (en) Pyrazolo [1, 5 – a ] pyrimidines as antiviral agents
EP2751112A4 (de) Substituierte pyrazolo[3,4-d]pyrimidine und ihre verwendung
PT2794611T (pt) Pirazolo[1,5-a]pirimidinas como agentes antivirais
IL227526A0 (en) Derivatives of 6-cyclobutyl-1,5-dihydro-pyrazolo [3,4-d] pyrimidine-4-one and their use as a9pde inhibitors
HK1176236A1 (en) Thiazolo[5,4-d] pyrimidines and their use as agrochemicals [54-d]
IL229606A0 (en) Pyrazolone [3, 4-d] pyrimidine compounds and their use as 2pde inhibitors and/or 4a3 cyp inhibitors
AP2012006631A0 (en) 6-Cycloalkyl-1, 5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A inhibitors
ZA201403441B (en) [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid
ZA201406323B (en) Triazolo[4,5-d]pyrimidine derivatives
HK1193806A1 (zh) 噻吩並 嘧啶衍生物及其用於治療心律失常的用途
PT2920174T (pt) Compostos de pirazolo[3,4-d]pirimidina substituídos, preparação e utilização dos mesmos como ligantes recetores sigma
SG10201602846TA (en) 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents